Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
News Analysis: German pharma industry grows, but patent, tariff pressures cloud outlook
BERLIN, Jan. 14 (Xinhua) -- Parts of Germany's health and life sciences industry, led by research-driven pharmaceutical companies, have continued to hire, invest, and expand, even as the broader manufacturing economy struggles to regain momentum.
Pharma CEOs Vent Vaccine Anger During Largest Industry Gathering
This article is for subscribers only. Hi, it's Madison and Gerry in San Francisco, where the biggest health care conference of the year is underway. While the JPMorgan shindig is known for seeding mergers and acquisitions, it also offers a safe…
Irish pharma wholesaler Uniphar acquires Limerick's Touchstone
Uniphar, which recently made a significant investment in a new distribution facility in Dublin, said the deal provides long-term backing for TouchStore's products, while enabling Uniphar to unlock greater service offerings for its wholesale…
Big Pharma enters 2026 with an appetite for deals
Revolution Medicines CEO Mark Goldsmith, whose company might be at the center of what could wind up being the biggest biotech deal of the year, is staying tight-lipped. His company, a California-based startup working on a late-stage oral cancer…
Torrent Pharma to sell largest acquisition-funding debt this FY, bankers say
, India's Torrent Pharmaceuticals plans to raise 110 billion rupees ($1.22 billion) through multiple maturity bonds in what would be the largest acquisition-funding deal so far this financial year, two bankers said…
Eastern Bank Boosts Stake in Royalty Pharma PLC $RPRX
Eastern Bank lifted its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 1,368.2% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 371,255…
Healthy Returns: Novo Nordisk CEO on GLP-1 pricing, and more insights from the JPM conference
Novo Nordisk CEO Mike Doustdar said 2026 will be the year of 'price pressure' as more GLP-1 supply enters the market and pricing deals take effect. Bristol Myers Squibb CEO Chris Boerner said the company has the potential to deliver up to 10 new…
Stock markets extend losses for 2nd day
Equity benchmark indices Sensex and Nifty declined on Wednesday, extending their previous day's losses, due to weakness in IT, consumption, and select banking blue-chip stocks amid escalating geopolitical tensions. Besides, persistent foreign fund…
Revanth to Unveil NextGen Life Sciences Policy at Davos
Hyderabad: Chief Minister A. Revanth Reddy will launch the Telangana NextGen Life Sciences Policy 2026-30 during the World Economic Forum (WEF) Summit at Davos next week, positioning the state as a global leader in life sciences and healthcare…
Off the Scales by Aimee Donnellan review - inside the Ozempic revolution
Few aspects of being human have generated more judgment, scorn and condemnation than a person's size, shape and weight – particularly if you happen to be female. As late as 2022, the Times's columnist Matthew Parris published a column…
Exclusive | Welcome to the 'peptide gray market': where people are buying GLP-1s, Botox and filler on social media from China
The pandemic changed how Americans think about health — and who they trust to manage it. In the wreckage of lockdowns, millions turned away from doctors and toward influencers. Now, a growing number of wellness creators and everyday people…
Simon Harris meets with Donald Trump's nemesis Gavin Newsom in California
Tánaiste Simon Harris had a “warm and constructive” meeting today with US President Donald Trump's nemesis Gavin Newsom. On an official visit to California, the Foreign Affairs Minister met with Mr Newsom, the state's mayor.
Santhera Receives Swissmedic Approval of AGAMREE (Vamorolone) for the Treatment of Duchenne Muscular Dystrophy
Commercial launch in Switzerland anticipated in H2 2026 Pratteln, Switzerland, January 15, 2026 – Santhera Pharmaceuticals (SIX: SANN) announces that the Swiss Agency for Therapeutic Products (Swissmedic), has approved AGAMREE (vamorolone)…
Stock markets extend losses for 2nd day; Sensex drops 245 points
Equity benchmark indices Sensex and Nifty declined on Wednesday (January 14, 2026), extending their previous day's losses, due to weakness in IT, consumption, and select banking blue-chip stocks amid escalating geopolitical tensions. Besides…
Pro-trans pediatric group wins $12 million as judge slams Kennedy's 'retaliatory' cuts
A U.S. District Court judge sided with the American Academy of Pediatrics (AAP) late Sunday night in a ruling that temporarily restores $12 million in funding to the group. Health and Human Services (HHS) Secretary Robert F. Kennedy abruptly…
Receive a Daily briefing on Pharma Industry News
Get Started